Galafold 123 MG

Ended Awarded

Contract number
36C24524N0205
Awardee
Awarding agency
Obligated
$20,125

Award facts

Contract value 100% obligated
$20,124.91 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs Veterans Health Administration awarded a $20,125 delivery order against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs GSA Schedule contract. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will provide GALAFOLD 123 MG to Veterans Integrated Service Network 5 in Philadelphia, Pennsylvania from December 6-8, 2023. The firm fixed price order supports the VA's mission to provide quality healthcare to veterans through its Veterans Health Administration programs. No subcontractors or set aside designations were identified.

Quick answers

Who was awarded contract 36C24524N0205?

36C24524N0205 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 6, 2023.

How much is contract 36C24524N0205 worth?

The government has obligated $20,125 on 36C24524N0205.

Is contract 36C24524N0205 an order under another contract?

Yes. 36C24524N0205 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0205 competed?

The extent of competition for 36C24524N0205 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award